Dr. Susan Modesitt of Emory Healthcare is joining us on May 22 to discuss the risks, screening, and treatments for gynecologic, hereditary, and obesity-related cancers.
Susan C. Modesitt, MD, FACOG, FACS, is a professor and the director of the Division of Gynecologic Oncology in the Department of Gynecology and Obstetrics at Emory University School of Medicine. Dr. Modesitt leads the gynecologic oncology program at Winship Cancer Institute of Emory University. A board-certified gynecologic oncologist, Dr. Modesitt specializes in the treatment of gynecologic malignancies and is an attending based primarily at Emory University Hospital Midtown and Emory University Hospital. Prior to joining Emory, she was a professor and the division director of gynecologic oncology at the University of Virginia.
Dr. Modesitt is a fellow of the American College of Obstetricians and Gynecologists and the American College of Surgeons and has served in multiple leadership roles and committees for the Society of Gynecologic Oncology, American College of Obstetricians and Gynecologists, American Board of Obstetrics and Gynecology, and NRG Oncology.
Dr. Modesitt completed medical school at the University of Virginia in Charlottesville, her obstetrics and gynecology residency at the University of North Carolina in Chapel Hill, and her gynecologic oncology fellowship at the M.D. Anderson Cancer Center.
Dr. Modesitt’s research focuses on hereditary cancers, obesity-related cancers, and clinical trials in gynecologic oncology.
Dr. Modesitt serves as editor-in-chief of Gynecologic Oncology Reports. She has published extensively on gynecologic cancers.